FDA Approved: TAGAMET — Supplemental Application (Prestige Brands Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Tagamet (cimetidine) from Prestige Brands Holdings, Inc., resulting in an updated product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease

Drugs mentioned

• TAGAMET (CIMETIDINE)

Snippet

SUPPL AP for TAGAMET (CIMETIDINE)